Device type · MAF
Stent, Coronary
Last checked: Nov 19, 2026Source: openFDAMethods & limitations
Product code
MAF
Cardiovascular
Device class
Class III
FDA decisions since 2015
4
510(k), De Novo and PMA
Adverse event reports
33
Received Nov 1, 2025 to Nov 19, 2026
How FDA classifies it
- Device type
- Stent, Coronary
- Product code
- MAF
- Device class
- Class III
- Review panel
- Cardiovascular
- Specialty
- Cardiology, Interventional Cardiology
- FDA record
- Classification database entry for MAF
Latest FDA decisions
P130030 · Decided Mar 10, 2026 · 4,453 days after receipt
Device type: STENT, CORONARY (MAF) · Cardiology
P150039 · Decided Feb 21, 2017 · 480 days after receipt
Device type: STENT, CORONARY (MAF) · Cardiology
P160014 · Decided Feb 21, 2017 · 295 days after receipt
Device type: STENT, CORONARY (MAF) · Cardiology
1 more FDA decisions with a free account
Reports received
33
Received Nov 1, 2025 to Nov 19, 2026. Includes 1 of another or unstated type.
Malfunction reports
15
45% of reports
Injury reports
14
42% of reports
Death reports
3
9.1% of reports
Adverse event reports received per month
By the date FDA received each report, stacked by event type. The newest month is incomplete.
- Malfunction
- Injury
- Death
- Other
View as table
| Month | Malfunction | Injury | Death | Other |
|---|---|---|---|---|
| Dec 23 | 2 | 19 | 0 | 0 |
| Jan 24 | 5 | 20 | 0 | 0 |
| Feb 24 | 2 | 17 | 0 | 0 |
| Mar 24 | 2 | 17 | 1 | 0 |
| Apr 24 | 3 | 15 | 0 | 0 |
| May 24 | 4 | 21 | 0 | 0 |
| Jun 24 | 2 | 17 | 0 | 0 |
| Jul 24 | 4 | 12 | 2 | 0 |
| Aug 24 | 6 | 13 | 0 | 0 |
| Sep 24 | 2 | 7 | 0 | 0 |
| Oct 24 | 2 | 7 | 1 | 0 |
| Nov 24 | 0 | 22 | 0 | 0 |
| Dec 24 | 1 | 14 | 0 | 0 |
| Jan 25 | 1 | 11 | 0 | 0 |
| Feb 25 | 1 | 8 | 0 | 0 |
| Mar 25 | 2 | 9 | 0 | 0 |
| Apr 25 | 9 | 9 | 0 | 0 |
| May 25 | 2 | 6 | 0 | 0 |
| Jun 25 | 1 | 10 | 0 | 0 |
| Jul 25 | 3 | 7 | 1 | 0 |
| Aug 25 | 0 | 12 | 1 | 0 |
| Sep 25 | 2 | 8 | 0 | 0 |
| Oct 25 | 0 | 6 | 0 | 0 |
| Nov 25 | 2 | 1 | 0 | 0 |
| Dec 25 | 4 | 0 | 0 | 0 |
| Jan 26 | 1 | 6 | 3 | 0 |
| Feb 26 | 1 | 1 | 0 | 0 |
| Mar 26 | 2 | 2 | 0 | 0 |
| Apr 26 | 0 | 2 | 0 | 0 |
| May 26 | 0 | 1 | 0 | 0 |
| Jun 26 | 1 | 0 | 0 | 1 |
| Jul 26 | 2 | 1 | 0 | 0 |
| Aug 26 | 0 | 0 | 0 | 0 |
| Sep 26 | 2 | 0 | 0 | 0 |
| Oct 26 | 0 | 0 | 0 | 0 |
| Nov 26 | 0 | 0 | 0 | 0 |
Manufacturers named most often
Last 12 months. Bigger sellers get more reports. This is not a ranking of safety.
- Abbott15
1 more in this ranking with a free account
Device problems as coded
Last 12 months. FDA's terms. A report can carry several.
- Adverse Event Without Identified Device or Use Problem15
- Activation Failure6
- Deformation Due to Compressive Stress4
7 more in this ranking with a free account
Patient problems as coded
Last 12 months. FDA's terms. A report can carry several.
- No Clinical Signs, Symptoms or Conditions17
- Stenosis4
- Unspecified Heart Problem3
7 more in this ranking with a free account
Recent recalls
From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.
Z-0580-2020 · Started Oct 24, 2019
Reason given: Certain dilation and extension catheters are being recalled because these catheters may have missed the hydrophilic coating step, which creates a lubricious surface on the devices, during the manufacturing process.
Cause as FDA categorized it: Process control
Z-1826-2017 · Started Feb 16, 2017
Reason given: Deployment Difficulty.
Cause as FDA categorized it: Other
Z-0068-2010 · Started Sep 11, 2009 · Posted by FDA Oct 21, 2009
Reason given: Boston Scientific initiated a field correction for the Liberte Bare-Metal coronary stent products. They have received reports from cardiac cath labs that TAXUS Liberte Paclitaxel-Eluting (TAXUS Libert Drug-Eluting) coronary stents have been inadvertently selected when the interventional cardiologist intended to...
Cause as FDA categorized it: Labeling design
19 more recall records with a free account
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.